- Home
- TCBI vs ACLX Comparison
TCBI vs ACLX Comparison
Compare TCBI & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBI
- ACLX
- Stock Information
- Founded
- TCBI 1996
- ACLX 2015
- Country
- TCBI United States
- ACLX United States
- Employees
- TCBI N/A
- ACLX N/A
- Industry
- TCBI Major Banks
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- TCBI Finance
- ACLX Health Care
- Exchange
- TCBI Nasdaq
- ACLX Nasdaq
- Market Cap
- TCBI 3.9B
- ACLX 4.4B
- IPO Year
- TCBI N/A
- ACLX 2022
- Fundamental
- Price
- TCBI $86.26
- ACLX $86.08
- Analyst Decision
- TCBI Hold
- ACLX Strong Buy
- Analyst Count
- TCBI 10
- ACLX 10
- Target Price
- TCBI $85.20
- ACLX $117.50
- AVG Volume (30 Days)
- TCBI 589.2K
- ACLX 402.5K
- Earning Date
- TCBI 10-22-2025
- ACLX 11-05-2025
- Dividend Yield
- TCBI N/A
- ACLX N/A
- EPS Growth
- TCBI 2948.16
- ACLX N/A
- EPS
- TCBI 6.10
- ACLX N/A
- Revenue
- TCBI $1,149,977,000.00
- ACLX $35,898,000.00
- Revenue This Year
- TCBI $47.92
- ACLX N/A
- Revenue Next Year
- TCBI $7.81
- ACLX $220.95
- P/E Ratio
- TCBI $14.23
- ACLX N/A
- Revenue Growth
- TCBI 39.14
- ACLX N/A
- 52 Week Low
- TCBI $59.37
- ACLX $47.86
- 52 Week High
- TCBI $94.61
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- TCBI 55.80
- ACLX 52.73
- Support Level
- TCBI $81.27
- ACLX $84.00
- Resistance Level
- TCBI $86.28
- ACLX $90.30
- Average True Range (ATR)
- TCBI 2.42
- ACLX 3.57
- MACD
- TCBI 0.34
- ACLX -0.31
- Stochastic Oscillator
- TCBI 88.79
- ACLX 42.53
About TCBI Texas Capital Bancshares Inc.
Texas Capital Bancshares Inc is a registered bank holding company and a full-service financial services firm that delivers customised solutions to businesses, entrepreneurs and individual customers. It is a secured lender with the majority of the loans held for investment, excluding mortgage finance loans and other national lines of business. Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.